Feline Infectious Peritonitis (FIP): Diagnosis, Clinical Signs, and the GS-441524 Antiviral Revolution

1. Pathogenesis: How Common Coronavirus Becomes Fatal FIP

Feline enteric coronavirus (FCoV) is highly prevalent in multicat environments, transmitted via the fecal-oral route and typically causing only self-limiting diarrhea. In roughly 5-10% of infected felines, particularly young kittens under two years of age or stressed cats, the virus undergoes internal genetic mutations in key replication genes.

This mutation alters cellular tropism: the virus leaves the gut epithelium and gains the ability to replicate efficiently inside host macrophages. Circulating infected immune cells deposit in blood vessels throughout the body, triggering systemic pyogranulomatous vasculitis and severe immune-complex deposition.

---

2. Wet vs. Dry FIP: Identifying Signs and Symptoms

• Effusive (Wet) FIP: Characterized by hyperpermeable vascular leakage. Owners observe rapid, painless abdominal enlargement ('fluid belly') or severe dyspnea caused by pleural effusion. This form tends to progress rapidly over days or weeks.
• Non-Effusive (Dry) FIP: Develops insidiously over months. Typical signs include fluctuating antibiotic-resistant fever, unkempt coat, lethargy, muscle wasting, and stunted growth in kittens.
• Neurological & Ocular Signs: Corneal precipitates, anterior uveitis, hyphema, ataxia, tremors, behavioral changes, and seizures indicate that the virus has crossed protective blood-brain or blood-ocular barriers.

---

3. Veterinary Diagnosis & Laboratory Workup

Accurate diagnosis requires synthesizing multiple laboratory findings:

1. Serum Biochemistry: Inverted A:G ratio (less than 0.6 is highly indicative of FIP), high total protein with hypergammaglobulinemia, and elevated acute-phase protein SAA.
2. Effusion Analysis: Clear to straw-colored, viscous fluid with high protein content (>35 g/L), low cellularity, and a positive Rivalta test.
3. Molecular Testing: Quantitative RT-PCR identifying specific spike gene mutations in effusion fluid or fine-needle tissue aspirates.

---

4. The GS-441524 Antiviral Protocol

GS-441524 is a small-molecule adenosine nucleoside analog that acts as a competitive chain terminator for viral RNA-dependent RNA polymerase, halting FIP virus replication immediately.

• Treatment Duration: Exactly 84 days (12 weeks) administered every 24 hours without missed doses.
• Route: Subcutaneous injection or palatable oral tablets.
• Dosage Tiers: 5-6 mg/kg for uncomplicated wet/dry FIP, 8-10 mg/kg for ocular involvement, and 10-15 mg/kg for neurological FIP to penetrate the blood-brain barrier.
• Post-Treatment Observation: An 84-day drug-free observation phase follows; if bloodwork remains normal and no relapse occurs, the cat is officially declared cured.

---

Scientific Sources and References

• Pedersen, N. C., et al. (2019). Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. Journal of Feline Medicine and Surgery, 21(4), 271-281.
• Tasker, S. (2018). Diagnosis of feline infectious peritonitis: update on evidence supporting available tests. Journal of Feline Medicine and Surgery, 20(3), 228-243.
• European Advisory Board on Cat Diseases (ABCD). Feline Infectious Peritonitis Guidelines: Update on Antiviral Therapies. ABCDcatvets.org, 2023.
• Hartmann, K. (2005). Feline infectious peritonitis. Veterinary Clinics of North America: Small Animal Practice, 35(1), 39-79.